The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms
Open accessThe DOI matches its Crossref record; 96 of the 99 references it cites were found in a registry or an index; 32 of the 142 sources its claims cite were checked for support.
Abstract
Recent evidence demonstrates that tobacco smoking causes an imbalance in bone turnover, leading to lower bone mass and making bone vulnerable to osteoporosis and fracture. Tobacco smoke influences bone mass indirectly through alteration of body weight, parathyroid hormone-vitamin D axis, adrenal hormones, sex hormones, and increased oxidative stress on bony tissues. Also, tobacco smoke influences bone mass through a direct effect on osteogenesis and angiogenesis of bone. A RANKL-RANK-OPG pathway is an essential regulatory pathway for bone metabolism and its importance lies in its interaction with most of the pathophysiologic mechanisms by which smoking influences bone mass. Both first- and secondhand smoke adversely affect bone mass; smoking cessation seems to reverse the effect of smoking and improve bone health. Recent advances in research on bone turnover markers could advance scientific knowledge regarding the mechanisms by which smoking may influence bone mass.
Overview
CoChat Summary
TL;DR
This narrative review summarizes direct and indirect pathophysiologic mechanisms by which tobacco smoking reduces bone mass and increases osteoporosis and fracture risk, with the RANKL-RANK-OPG pathway as a central mediator. It also reviews secondhand smoke and smoking cessation effects, concluding that the mechanisms are complex and require further research.
Key findings
- Tobacco smoking causes an imbalance in bone turnover, leading to lower bone mass and BMD and greater vulnerability to osteoporosis and fracture; the Surgeon General causally linked smoking with skeletal disorders including hip fracture, rheumatoid arthritis, and periodontitis.
- Indirect mechanisms include lower body weight/BMI, altered PTH-vitamin D axis and calcium absorption, increased cortisol and adrenal androgens, altered sex hormones (including lower estradiol and menopause about two years earlier in women who smoke), and increased oxidative stress; smokers had lower antioxidant enzymes and higher oxidative stress products, and smokers with low intake of vitamins C and E had a fivefold increased risk of hip fracture compared with nonsmokers.
- Direct effects involve nicotine and polycyclic aryl hydrocarbons on osteoblasts/osteoclasts and angiogenesis; the RANKL-RANK-OPG pathway interacts with most indirect mechanisms. Smoke-exposed rats had higher RANKL/OPG ratios, and human smokers generally had lower OPG and higher RANKL/OPG ratios, though one study found lower RANKL and higher RANKL/OPG ratio in smokers that were not statistically significant.
- Secondhand smoke adversely affects bone: exposed subjects had significantly lower phalangeal BMD (p < 0.01) and higher risk for femoral neck osteoporosis (OR 3.68; 95% CI 1.23–10.92). Smoking cessation may reverse effects, with bone density improvement in less than 10 years and, in postmenopausal women, improvement in gonadal hormones and bone formation/resorption markers in 6 weeks and bone density after 1 year.
Methods
- Narrative overview/review with three aims: summarize pathophysiologic mechanisms of tobacco smoke on bone mass, discuss interactions with the RANKL-RANK-OPG pathway and bone turnover markers, and understand secondhand smoke and smoking cessation effects.
- No primary data collection or systematic search strategy is described; the paper synthesizes prior reviews, laboratory animal/cell studies, and human observational studies.
- Main analysis is a qualitative synthesis organized into indirect mechanisms, direct bone tissue effects, confounding factors, secondhand smoke, and smoking cessation.
Limitations
- The paper states that pathophysiologic mechanisms remain unclear because there are few appropriately designed studies to clarify mechanisms and some findings are contradictory; further research is needed.
- The paper notes that few studies have explored the relationship between smoking and the RANKL-RANK-OPG pathway and bone turnover markers in humans, and that the finding of lower RANKL in smokers was unexpected and may be affected by factors other than smoking.
- Evident from the text: as a narrative review without a described systematic search or meta-analysis, conclusions depend on selected literature, and many cited mechanistic findings come from animal/cell models and observational human studies, limiting causal inference.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
26 Valid · 2 Not valid · 50 Not checked · 13 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Low 25-hydroxy vitamin D (25-OH-D) and 1, 25-OH2-D in smokers were reported in several studies [20–27]”
§ The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms > 2. Effect of Smoking on Bone Mass: Pathophysiologic Mechanisms > 2.1. Indirect Mechanisms
What the sources say
- Not checked — no full text of the sourcecites [20] Landin-Wilhelmsen K. Wilhelmsen L. Lappas G. Serum intact parathyroid hormone in a random population sample of men and women: Relationship to anthropometry, life-style factors, blood pressure, and vitamin D Calcified Tissue International 1995 56 2 104 108 2-s2.0-0028938284 10.1007/BF00296339 7736316 source
- Not checked — no full text of the sourcecites [21] Brot C. Jøorgensen N. R. Sørensen O. H. The influence of smoking on vitamin D status and calcium metabolism European Journal of Clinical Nutrition 1999 53 12 920 926 2-s2.0-0032761761 10.1038/sj.ejcn.1600870 10602348 source
- Not checked — no full text of the sourcecites [22] Szulc P. Garnero P. Claustrat B. Marchand F. Duboeuf F. Delmas P. D. Increased bone resorption in moderate smokers with low body weight: The Minos study The Journal of Clinical Endocrinology & Metabolism 2002 87 2 666 674 2-s2.0-0036168323 10.1210/jc.87.2.666 11836302 source
- Not checked — no full text of the sourcecites [23] Need A. G. Kemp A. Giles N. Morris H. A. Horowitz M. Nordin B. E. C. Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women Osteoporosis International 2002 13 1 83 88 2-s2.0-0036168730 10.1007/s198-002-8342-9 11883410 source
- Not checked — no full text of the sourcecites [24] Lorentzon M. Mellström D. Haug E. Ohlsson C. Smoking is associated with lower bone mineral density and reduced cortical thickness in young men The Journal of Clinical Endocrinology & Metabolism 2007 92 2 497 503 2-s2.0-33846982935 10.1210/jc.2006-1294 17077132 source
- Not matchedcites [25] Kargin N. C. Marakoglu K. Unlu A. Kebapcilar L. Korucu E. N. Comparison of bone turnover markers between male smoker and non-smoker Acta Medica Mediterranea 2016 32 2 317 323 2-s2.0-84994259709
We searched by its title and found no matching paper.
- Partly supportedcites [26] Kassi E. N. Stavropoulos S. Kokkoris P. Smoking is a significant determinant of low serum vitamin D in young and middle-aged healthy males Hormones 2015 14 245 250 2-s2.0-84932601734 25402376 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports lower 25(OH)D in smokers in this study and describes other studies with similar findings. It does not report lower 1,25(OH)2D in smokers, so the claim is supported only for 25(OH)D. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [27] Christie J. Osborne R. Kantor S. Nowson C. Seibel M. Wark J. Mechanisms of bone loss in twins discordant for cigarette smoking Bone 2009 44 p. S103 10.1016/j.bone.2009.01.226 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The effect of smoking on suppression of PTH is inconsistently reported [20–23, 25, 28]”
§ The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms > 2. Effect of Smoking on Bone Mass: Pathophysiologic Mechanisms > 2.1. Indirect Mechanisms
What the sources say
- Not checked — no full text of the sourcecites [20] Landin-Wilhelmsen K. Wilhelmsen L. Lappas G. Serum intact parathyroid hormone in a random population sample of men and women: Relationship to anthropometry, life-style factors, blood pressure, and vitamin D Calcified Tissue International 1995 56 2 104 108 2-s2.0-0028938284 10.1007/BF00296339 7736316 source
- Not checked — no full text of the sourcecites [21] Brot C. Jøorgensen N. R. Sørensen O. H. The influence of smoking on vitamin D status and calcium metabolism European Journal of Clinical Nutrition 1999 53 12 920 926 2-s2.0-0032761761 10.1038/sj.ejcn.1600870 10602348 source
- Not checked — no full text of the sourcecites [22] Szulc P. Garnero P. Claustrat B. Marchand F. Duboeuf F. Delmas P. D. Increased bone resorption in moderate smokers with low body weight: The Minos study The Journal of Clinical Endocrinology & Metabolism 2002 87 2 666 674 2-s2.0-0036168323 10.1210/jc.87.2.666 11836302 source
- Not checked — no full text of the sourcecites [23] Need A. G. Kemp A. Giles N. Morris H. A. Horowitz M. Nordin B. E. C. Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women Osteoporosis International 2002 13 1 83 88 2-s2.0-0036168730 10.1007/s198-002-8342-9 11883410 source
- Not matchedcites [25] Kargin N. C. Marakoglu K. Unlu A. Kebapcilar L. Korucu E. N. Comparison of bone turnover markers between male smoker and non-smoker Acta Medica Mediterranea 2016 32 2 317 323 2-s2.0-84994259709
We searched by its title and found no matching paper.
- Supportedcites [28] Fujiyoshi A. Polgreen L. E. Gross M. D. Reis J. P. Sidney S. Jacobs D. R. Smoking habits and parathyroid hormone concentrations in young adults: The CARDIA study Bone Reports 2016 5 104 109 2-s2.0-84966376741 10.1016/j.bonr.2016.04.003 27795978 PMC4926833 source
The Introduction states that findings on smoking and PTH conflict: some studies report higher PTH in smokers, while others report lower PTH. The Discussion reiterates this inconsistency. The paper describes associations rather than establishing a causal effect of smoking. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Estrogen acts via suppression of bone resorption [43–45]”
§ The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms > 2. Effect of Smoking on Bone Mass: Pathophysiologic Mechanisms > 2.1. Indirect Mechanisms
What the sources say
- Not checked — no full text of the sourcecites [43] Prestwood K. M. Pilbeam C. C. Burleson J. A. The short term effects of conjugated estrogen on bone turnover in older women The Journal of Clinical Endocrinology & Metabolism 1994 79 2 366 371 2-s2.0-0028025049 10.1210/jc.79.2.366 8045949 source
- Not checked — no full text of the sourcecites [44] Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis Journal of Bone and Mineral Research 1996 11 8 1043 1051 2-s2.0-0029783770 8854239 source
- Supportedcites [45] Vega D. Maalouf N. M. Sakhaee K. The role of receptor activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin: clinical implications The Journal of Clinical Endocrinology & Metabolism 2007 92 12 4514 4521 10.1210/jc.2007-0646 2-s2.0-36849073746 17895323 source
The Postmenopausal osteoporosis section (p. 2) reports that estradiol increases osteoprotegerin expression, which is expected to reduce osteoclastic bone resorption. It also reports lower RANKL expression in estrogen-treated than untreated postmenopausal women. Together, these passages support the broad claim. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“This pathway interacts with other factors influencing bone turnover, such as prostaglandin E2 and interleukins [45, 69].”
§ The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms > 2. Effect of Smoking on Bone Mass: Pathophysiologic Mechanisms > 2.2. Direct Effect on Bone Tissue
What the sources say
- Supportedcites [45] Vega D. Maalouf N. M. Sakhaee K. The role of receptor activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin: clinical implications The Journal of Clinical Endocrinology & Metabolism 2007 92 12 4514 4521 10.1210/jc.2007-0646 2-s2.0-36849073746 17895323 source
The Regulatory Mechanisms of Bone Remodeling section (p. 1) says RANKL, RANK, and OPG act in conjunction with cytokines and identifies IL-1, IL-6, and IL-11 as regulators of osteoclast activity. The Fig. 1 caption (p. 2) identifies prostaglandin E2 among factors that modulate the RANKL/OPG balance. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [69] Leibbrandt A. Penninger J. M. RANK/RANKL: regulators of immune responses and bone physiology Annals of the New York Academy of Sciences 2008 1143 1 123 150 10.1196/annals.1443.016 2-s2.0-56549098575 19076348 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“the second study found lower mean BMD at age 17 in girls who had smoked and reported drinking at age 13 [83].”
§ The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms > 2. Effect of Smoking on Bone Mass: Pathophysiologic Mechanisms > 2.3. Confounding Factors
What the sources say
- Supportedcites [83] Lucas R. Fraga S. Ramos E. Barros H. Early Initiation of Smoking and Alcohol Drinking as a Predictor of Lower Forearm Bone Mineral Density in Late Adolescence: A Cohort Study in Girls PLoS ONE 2012 7 10 2-s2.0-84867627530 10.1371/journal.pone.0046940 e46940 23094033 PMC3475705 source
The Results section (“Smoking and/or drinking and 17-year-old bone mineral density”) reports lower mean forearm BMD at age 17 among girls who had tried both smoking and drinking before age 13 than among girls who had tried neither. The cited sentence accurately describes that finding. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
27 more claims · 3 with their cited sources checked
Create a free account to see all 91 claims and every source verdict.
- It may state two separate claims as one. 47
- Probably not a substantial claim. 21
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms > 2. Effect of Smoking on Bone Mass: Pathophysiologic Mechanisms > 2.2. Direct Effect on Bone Tissue
“Laboratory studies have found smoke-exposed male rats had significantly higher levels of TRACP and lower levels of OC and b-ALP activities than unexposed control rats [96].”
§ The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms > References
“96. Gao S.-g. Li K.-h. Xu M. Bone turnover in passive smoking female rat: relationships to change in bone mineral density”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms > 2. Effect of Smoking on Bone Mass: Pathophysiologic Mechanisms > 2.2. Direct Effect on Bone Tissue
“RANKL and OPG are members of the superfamily of tumor necrosis factor (TNF) and TNF receptor, respectively, and their binding to receptor activator of NF-kB (RANK) has a fundamental role regulating osteoclast formation, proliferation, activity, and survival [72].”
§ The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms > 2. Effect of Smoking on Bone Mass: Pathophysiologic Mechanisms > 2.2. Direct Effect on Bone Tissue
“OPG, a soluble receptor also produced by osteoblasts that acts as a decoy receptor and neutralizes RANKL, prevents RANKL from interacting with RANK”
Citations
Cites
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
Burge, R., Dawson-Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson, A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061113 · Cited by 4,026
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753
Body mass index as a predictor of fracture risk: A meta-analysis
De Laet, C., Kanis, J. A., Odén, A., Johanson, H., Johnell, O., Delmas, P., Eisman, J. A., Kroger, H., Fujiwara, S., Garnero, P., et al. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1863-y · Cited by 1,622
Feng, X., & McDonald, J. M. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130203 · Cited by 1,272
for the IOF-IFCC Bone Marker Standards Working Group, Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., et al. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1501-1 · Cited by 1,212
Lips, P. (2006) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2006.02.016 · Cited by 1,173 · cited 1×
“PTH is a hormone controlling the serum level of ionized calcium via bone resorption and renal absorption, while the active form of vitamin D [1, 25 Dihydroxyvitamin D (1, 25-OH2-D)] regulates intestinal absorption of calcium [18, 19].”
BackgroundSmoking and fracture risk: a meta-analysis
Kanis, J. A., Johnell, O., Oden, A., Johansson, H., De Laet, C., Eisman, J. A., Fujiwara, S., Kroger, H., McCloskey, E. V., Mellstrom, D., et al. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1640-3 · Cited by 999
Falahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10942 · Cited by 757 · cited 1×
“Estrogen acts via suppression of bone resorption [43–45]; testosterone has a direct effect on bone through the androgen receptors present in osteoblasts that enhance bone proliferation [46–50], or it has an indirect effect through the aromatization changes to estrogen [51].”
BackgroundEstrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Pacifici, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110802 · Cited by 741
Research works printed but not linked: 2
- Kargin N. C. Marakoglu K. Unlu A. Kebapcilar L. Korucu E. N. Comparison of bone turnover markers between male smoker and non-smoker Acta Medica Mediterranea 2016 32 2 317 323 2-s2.0-84994259709
- Lian J. B. Stein G. S. The cells of bone Dynamics of Bone and Cartilage Metabolism 2006 2nd San Diego, USA Academic Press 221 258
Cited by
Items 201–214 of 214
Shouman, M., Jaffa, A. A., & Jaffa, M. A. (2026) · BMC Nephrology · doi:10.1186/s12882-026-04976-0
“In addition, cigarette smoking adversely affects bone mass and is associated with double the odds of sarcoma [27, 28].”
Haibier, A., Lin, H., Liu, W., & Li, W. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1801604 · Cited by 1
Oxidative stress in bone healing: mechanisms, disease contexts, and therapeutic strategies
Fu, W., Pan, D., Liu, Y., He, Z., & Hu, X. (2026) · European journal of medical research · doi:10.1186/s40001-026-04478-7 · Cited by 3
Albakri, U., Sindi, A., Othman, B., et al. (2026) · doi:10.2196/preprints.100127
Osteoporosis and Periodontitis: Two‐Way Epidemiological and Mechanistic Evidence
Jia, C., Bhuvanagiri, G., Dulkanchainun, M., & Wang, C. (2026) · Journal of Periodontal Research · doi:10.1111/jre.70125 · Cited by 2
Zhang, R., Long, W., & Li, Y. (2026) · Tobacco Induced Diseases · doi:10.18332/tid/217959
“Substantial biological evidence confirms that tobacco smoke disrupts bone remodeling homeostasis, predisposing individuals to reduced bone mineral density and clinical osteoporosis, which consequently elevates fracture susceptibility 7 .”
Úbeda, J. L. B., Martínez, N., Vergés, J., Santiñà, M., Celaya, J. V., & Dávalos-Picazo, G. (2026) · Revista Internacional de Investigación en Adicciones · doi:10.28931/riiad.2026.420
Bhardwaj, P. (2026) · The Conversation · doi:10.64628/aai.nsktctcp6
Bhardwaj, P. (2026) · The Conversation · doi:10.64628/ade.yr6aducph
Smadi, Z., Irfan, B., McBee, K., Tesfaye, B., Phan, E. N., Mubarak, F., Boutros, M., & Pereira, D. E. (2026) · Journal of orthopaedic surgery · doi:10.1177/10225536261467961
“Nicotine has been shown to suppress osteogenesis while increasing the rate of bone turnover, thereby decreasing overall bone mass. 22 These effects were noted even in the presence of second-hand smoke, where other studies have showcased that individuals who were never-smokers had elevated risks of…”
Liang, D., Zhan, Z., Zhang, Y., & Yan, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1876521 · Cited by 1
Hassan, A. M., Abdallah, S. A., Al-Haidose, A., Al‐Hamdani, M., & Abdallah, A. M. (2026) · Tobacco Induced Diseases · doi:10.18332/tid/221015
“While smokers also benefited from a higher BMI, the effect was diminished, perhaps due to the oxidative stress and inflammation caused by smoking 6 .”
Kondameda, R., Kolliputi, S., & Kolliputi, N. (2026) · Respiratory Medicine · doi:10.1016/j.rmed.2026.109126 · Cited by 1
Ten tips to reduce fracture risk by non-pharmacologic interventions in CKD-associated osteoporosis
Hansen, D., Jørgensen, H. S., Kanbay, M., Fusaro, M., Salomo, L., Fleig, S. V., Mølsted, S., Ryg, J., Haarhaus, M. L., & Evenepoel, P. (2026) · Clinical Kidney Journal · doi:10.1093/ckj/sfag303
Metadata
- Authors
- Al-Bashaireh, A. M., Haddad, L. G., Weaver, M., Chengguo, X., Kelly, D. L., & Yoon, S.
- Affiliations
- University of Florida (US)
- University of North Carolina Wilmington (US)
- Professor, College of Pharmacy, University of Florida, Gainesville, FL, USA
- Corresponding author
- Al-Bashaireh, Ahmad M.
- Venue
- Journal of Osteoporosis
- Publisher
- Wiley
- Published
- 2018-12-02
- Volume
- 2018
- Pages
- 1-17
- ISSN
- 2042-0064 (ISSN-L)
- 2090-8059
- PMC
- PMC6304634
- OpenAlex
- W2903346619
- Cited by
- 209
- References
- 99
- Citations by year
- 2026: 24 · 2025: 27 · 2024: 32 · 2023: 46 · 2022: 26 · 2021: 29 · 2020: 18 · 2019: 7
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Osteoporosis (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Florida
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- smoking, bone mass, osteoporosis, bone turnover, RANK/RANKL/OPG pathway, sex hormones, adrenal hormones, oxidative stress, bone formation, angiogenesis, passive smoking, smoking cessation, bone turnover markers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
